Loading...
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.
Highlights

A collection of news and information related to MedImmune Inc. published by this site and its partners.

Sort By: Relevancy | Date | Type
Displaying items 1-12 of 28
» View wsbt.com items only
    Dec 5, 2012 |Story| Baltimore Sun
  1. Grotech Ventures chosen to invest state money in Maryland startups

    Grotech Ventures will be the first venture capital firm to invest in Maryland startup companies using $12 million in state money as part of the InvestMaryland program, state economic development officials said Wednesday. The firm was selected based on...

    Tags: U.S. Securities and Exchange Commission, Gaithersburg (Montgomery, Maryland), Entertainment, Annapolis, Politics

  2. Nov 18, 2012 |Story| Baltimore Sun
  3. MedImmune creating drug pipeline for AstraZeneca

    When Gail Folena-Wasserman joined Gaithersburg biotechnology startup MedImmune in 1991, she was its first employee in research and development, and dreamed of what the company might be "when it grew up."
    When Gail Folena-Wasserman joined Gaithersburg biotechnology startup MedImmune in 1991, she was its first employee in research and development, and dreamed of what the company might be "when it grew up." Two decades later, the senior vice president for...

    Tags: Lupus, Diabetes, Mergers, Acquisitions and Takeovers, Medical Research, Leukemia

  4. Jul 16, 2012 |Story| Baltimore Sun
  5. Industrial employment in Baltimore-Washington area falls 2.3%

    Industrial employment in Maryland and Washington, D.C., fell 2.3 percent in a year-over-year period ending in May, with layoffs at defense contractor AAI Corp. and the closure of the Solo Cup plant in Owings Mills contributing to job losses,...

    Tags: Employment, Owings Mills (Baltimore, Maryland), Career and Workplace, General Motors Corp., White Marsh

  6. Jul 16, 2012 |Story| Baltimore Sun
  7. GlaxoSmithKline to acquire Human Genome Sciences

    After spurning a hostile takeover bid from GlaxoSmithKline PLC in April, Human Genome Sciences Inc. said Monday it agreed to be bought by the biopharmaceutical giant for a more lucrative offer valued at $3.6 billion.
    After spurning a hostile takeover bid from GlaxoSmithKline PLC in April, Human Genome Sciences Inc. said Monday it agreed to be bought by the biopharmaceutical giant for a more lucrative offer valued at $3.6 billion. GlaxoSmithKline boosted its offer for...

    Tags: Lupus, Bristol Myers Squibb Company, Human Genome Sciences Inc., Diabetes, Benlysta (drug)

  8. Mar 1, 2012 |Story| Baltimore Sun
  9. FDA approves new flu vaccine

    <a title="U.S. Food and Drug Administration" href="http://www.fda.gov/" target="_blank">The U.S. </a><a class="runtimeTopic" href="#">Food and Drug Administration</a> has approved a new vaccine to prevent the seasonal flu.
    The U.S. Food and Drug Administration has approved a new vaccine to prevent the seasonal flu. FluMist Quadrivalent is the first vaccine to contain four strains of the influenza virus - two influenza A strains and two B strains. It is manufactured by...

    Tags: FluMist (vaccine), Preventative Medicine, Flu, Flu Vaccine, Health Organizations

  10. Mar 15, 2012 |Story| Baltimore Sun
  11. Maryland raises $84 million to invest in tech startups

    Maryland succeeded in raising $84 million to invest in promising technology companies across the state via a novel online auction of tax credits, officials announced Thursday. The InvestMaryland plan, a cornerstone of Gov. Martin O'Malley's legislative...

    Tags: Barack Obama, Education, Politics, Google Inc., Executive Branch

  12. May 5, 2012 |Story| Baltimore Sun
  13. State biotech firms hope Congress will act

    A proposal to speed the approval of new prescription drugs has patient advocates and biotech firms &#8212; including many based in Maryland &#8212; hoping that Congress will deliver a rare dose of bipartisanship this year.
    A proposal to speed the approval of new prescription drugs has patient advocates and biotech firms — including many based in Maryland — hoping that Congress will deliver a rare dose of bipartisanship this year. Lawmakers are proposing a 6...

    Tags: Lobbying, Health Organizations, Politics, Barbara A. Mikulski, Bernard Sanders

  14. May 18, 2012 |Story| Baltimore Sun
  15. Report: Clinical trials of new medications help create jobs in Maryland

    Maryland has hosted 1,775 clinical trials for new medicines targeting six major chronic diseases since 1999, including 369 that are still in the early stages of recruiting patients, according to a study by two pharmaceutical industry groups released...

    Tags: Diabetes, Politics, Executive Branch, Medical Research, University of Maryland, College Park

  16. Apr 21, 2012 |Story| Baltimore Sun
  17. Consolidation wave poised to hit state's health care services, biopharma sectors

    Like a one-two punch, two major Maryland employers in the health care service and pharmaceutical industries were the targets last week of multibillion-dollar acquisition deals. Both homegrown companies — Human Genome Sciences Inc. and Catalyst...

    Tags: Lupus, Human Genome Sciences Inc., Benlysta (drug), Cigna Corporation, Mergers, Acquisitions and Takeovers

  18. Sep 13, 2011 |Story| Petoskey News
  19. Time for flu shots, and some may get a tiny needle

    WASHINGTON &mdash; It&rsquo;s flu vaccine time again &mdash; and some lucky shot-seekers will find that the needle has shrunk.
    WASHINGTON — It’s flu vaccine time again — and some lucky shot-seekers will find that the needle has shrunk. The first flu shot that works with a less-scary skin prick instead of an inch-long needle is hitting the market this fall....

    Tags: Asthma, FluMist (vaccine), Preventative Medicine, Flu, Flu Vaccine

  20. Jul 5, 2011 |Story| Baltimore Sun
  21. Maryland's biotech pitch: We know the Feds

    In a conference room in downtown Baltimore, F. Blix Winston compared the Food and Drug Administration to a "slow-moving bulldog."
    In a conference room in downtown Baltimore, F. Blix Winston compared the Food and Drug Administration to a "slow-moving bulldog." "You don't want to get bitten," Winston, an expert on the federal regulation of medical devices, told a crowd of about 50...

    Tags: Health Organizations, Colleges and Universities, Marketing, Human Genome Sciences Inc., Politics

  22. May 1, 2011 |Story| Baltimore Sun
  23. Lost 'Fortune'

    Walk the streets of downtown Baltimore, and you might feel the presence of its corporate ghosts. On Gay Street, perhaps you'll meet Alexander Brown, the Irish immigrant who started the nation's first investment firm here more than 200 years ago.
    Walk the streets of downtown Baltimore, and you might feel the presence of its corporate ghosts. On Gay Street, perhaps you'll meet Alexander Brown, the Irish immigrant who started the nation's first investment firm here more than 200 years ago. Head...

    Tags: Employees, Colleges and Universities, Ed Hale, Annapolis, Mergers, Acquisitions and Takeovers

 1  2 3Next >
Original site for MedImmune Inc. topic gallery.
Loading...
 
 

Date:

Credit:

User-submitted

Tags:

Rate:
Sending...

E-mail this photo

Error: malformed email address(es)
Both "from" and "recipient" email fields are required.

Recipient E-mail Addresses

(up to 3, separated by commas) Send me a copy.

From:

e-mail | buy this photo | link to photo
MedImmune Inc. Photos
MedImmune is one of the state's largest drug makers.
(May 1, 2012)
MedImmune
MedImmune employs 2,700 people in Maryland.
(May 1, 2012)
Medimmune
brochure -- "We're going to be able to allocate $75 mil...
(April 15, 2011)
My Desk, My Life: Christian Johansson